Skip to main content

Advertisement

Log in

Prospective and randomized comparison of electrical stimulation of the posterior tibial nerve versus oxybutynin versus their combination for treatment of women with overactive bladder syndrome

  • Original Article
  • Published:
World Journal of Urology Aims and scope Submit manuscript

Abstract

Objective

To verify whether the combination of transcutaneous electrical neural stimulation (TENS) with oxybutynin in the treatment of women with overactive bladder (OAB) would be more effective than isolated treatments.

Methods

We randomized 75 women with OAB, in three groups: GI—30 min TENS, twice a week; GII—daily slow release 10 mg oxybutynin; and GIII—TENS + oxybutynin (multimodal); all for 12 weeks. Patients were evaluated with validated questionnaires International Consultation on Incontinence-Short Form (ICIQ-SF), International Consultation on Incontinence-OAB (ICIQ-OAB), Symptom bother, and 3-day Voiding diary at weeks 0, 12, and 24.

Results

The groups were similar before treatment. After treatment, all groups significantly improved in OAB symptoms and quality of life (QoL). At week 12, ICIQ-OAB scores were 5.9, 4.6, and 2.9, in groups I, II, and III, respectively, p = 0.01. At week 24, GI and GIII kept the scores of the end of treatment (week 12), while GII increased ICIQ-OAB from 4.6 to 9.2, p = 0.0001, ICIQ-SF from 9.8 to 13.3, p = 0.0006, and Symptom bother score from 3.4 to 7.0, p = 0.0001.

Conclusions

The multimodal treatment was more effective and TENS alone or in association presented longer lasting results for improvement of clinical symptoms of OAB and QoL.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Abrams P, Cardozo L, Fall M et al (2002) The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn 21:167–178

    Article  PubMed  Google Scholar 

  2. Abrams P, Cardozo L, Wein A (2012) 3rd international consultation on incontinence–research society 2011. Neurourol Urodyn 31:291–292

    Article  PubMed  Google Scholar 

  3. Bellette PO, Rodrigues Palma PC, Hermann V et al (2009) Posterior tibial nerve stimulation in the management of overactive bladder: a prospective and controlled study. Actas Urol Esp 33:58–63

    Article  PubMed  Google Scholar 

  4. Mattiasson A, Blaakaer J, Hoye K et al (2003) Simplified bladder training augments the effectiveness of tolterodine in patients with an overactive bladder. BJU Int 91:154–160

    Article  Google Scholar 

  5. Burton C, Sajja A, Latthe PM (2012) Effectiveness of percutaneous posterior tibial nerve stimulation for overactive bladder: a systematic review and meta-analysis. Neurourol Urodyn 31:1206–1216

    Article  CAS  PubMed  Google Scholar 

  6. Rai BP, Cody JD, Alhasso A et al (2012) Anticholinergic drugs versus non-drug active therapies for non-neurogenic overactive bladder syndrome in adults. Cochrane Database Syst Rev 12:CD003193

    PubMed  Google Scholar 

  7. Pelletier EM, Vats V, Clemens Q (2009) Pharmacotherapy adherence and costs versus nonpharmacologic management in overactive bladder. Am J Manag Care 15:S108–S114

    PubMed  Google Scholar 

  8. Anderson KE (2004) Antimuscarinics for treatment of overactive bladder. Lancet Neurol 3:46–53

    Article  Google Scholar 

  9. Govier FE, Litwiller S, Nitti V et al (2001) Percutaneous afferent neuromodulation for the refractory overactive bladder: results of a multicenter study. J Urol 165:1193–1198

    Article  CAS  PubMed  Google Scholar 

  10. Peters KM, MacDiarmid SA, Wooldridge LS et al (2009) Randomized trial of percutaneous tibial nerve stimulation versus extended-release tolterodine: results from the overactive bladder innovative therapy trial. J Urol 182:1055–1061

    Article  CAS  PubMed  Google Scholar 

  11. Tellenbach M, Schneider M, Mordasini L et al (2012) Transcutaneous electrical nerve stimulation: an effective treatment for refractory non-neurogenic overactive bladder syndrome? World J Urol. doi:10.1007/s00345-012-0888-z

    PubMed  Google Scholar 

  12. Goode PS, Burgio KL, Locher JL et al (2002) Urodynamic changes associated with behavioral and drug treatment of urge incontinence in older women. J Am Geriatr Soc 50:808–816

    Article  PubMed  Google Scholar 

  13. MacDiarmid SA, Peters KM, Shobeiri SA et al (2010) Long-term durability of percutaneous tibial nerve stimulation for the treatment of overactive bladder. J Urol 183:234–240

    Article  PubMed  Google Scholar 

  14. Levin PJ, Wu JM, Kawasaki A et al (2012) The efficacy of posterior tibial nerve stimulation for the treatment of overactive bladder in women: a systematic review. Int Urogynecol J 23:1591–1597

    Article  PubMed  Google Scholar 

Download references

Conflict of interest

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Leonardo O. Reis.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (TIFF 795 kb)

Supplementary material 2 (TIFF 1520 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Souto, S.C., Reis, L.O., Palma, T. et al. Prospective and randomized comparison of electrical stimulation of the posterior tibial nerve versus oxybutynin versus their combination for treatment of women with overactive bladder syndrome. World J Urol 32, 179–184 (2014). https://doi.org/10.1007/s00345-013-1112-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00345-013-1112-5

Keywords

Navigation